Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Gain of function mutations in p53

D Dittmer1, S Pati, G Zambetti

  • 1Department of Molecular Biology, Princeton University, New Jersey 08544-1014.

Nature Genetics
|May 1, 1993
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Author Correction: Universal DNA methylation age across mammalian tissues.

Nature aging·2023
Same author

Universal DNA methylation age across mammalian tissues.

Nature aging·2023
Same author

Pathological and cytological changes of the nasal mucosa in acute rhinosinusitis: the role of hyaluronic acid as supportive therapy.

European review for medical and pharmacological sciences·2017
Same author

Spatial distributions of pericellular stiffness in natural extracellular matrices are dependent on cell-mediated proteolysis and contractility.

Acta biomaterialia·2017
Same author

The association between physical activity and cognition in men with and without HIV infection.

HIV medicine·2017
Same author

Ancillary therapy of intranasal T-LysYal® for patients with allergic, non-allergic, and mixed rhinitis.

Journal of biological regulators and homeostatic agents·2016
Same journal

Mutational scanning reveals substrate-assisted autoregulation of the WNT destruction complex.

Nature genetics·2026
Same journal

Spatial transcriptomic analyses highlight distinct erythroid niches in mice and humans.

Nature genetics·2026
Same journal

Building up pangenome analysis block by block.

Nature genetics·2026
Same journal

Mutations in splicing factor gene U2AF1 rescue defective oncogene splicing in KRAS-mutant cancers.

Nature genetics·2026
Same journal

Assessing the effect of immune surveillance on clonal expansions in the blood.

Nature genetics·2026
Same journal

Improved heritability partitioning and enrichment analyses using summary statistics with graphREML.

Nature genetics·2026
See all related articles

Mutant p53 proteins can gain new functions, enhancing cell tumorigenicity and gene expression. This gain of function complements the previously known loss of function associated with p53 mutations.

Area of Science:

  • Oncology
  • Molecular Biology
  • Genetics

Background:

  • Tumor suppressor genes, like p53, play critical roles in preventing cancer.
  • Mutations in p53 are common in human cancers and are traditionally associated with a loss of its tumor-suppressive functions.
  • The functional consequences of p53 mutations beyond loss of function are not fully understood.

Purpose of the Study:

  • To investigate whether mutant p53 proteins can confer new or additional functions to cells lacking endogenous p53.
  • To determine if mutant p53 expression impacts cellular phenotypes such as tumorigenicity and gene regulation.

Main Methods:

  • Expression of murine or human mutant p53 proteins in p53-null cell lines (e.g., mouse (10)3 cells, human SAOS-2 cells).
  • Assessment of tumorigenic potential in nude mice.

Related Experiment Videos

  • Evaluation of plating efficiency in agar cell culture.
  • Analysis of the effect of mutant p53 on the expression of a reporter gene regulated by the multi-drug resistance enhancer-promoter element.

    • Main Results:

    • Expression of mutant p53 in p53-null cells resulted in enhanced tumorigenic potential in vivo.
    • Mutant p53 expression led to increased plating efficiency in soft agar, indicating altered cell growth characteristics.
    • Unlike wild-type p53, mutant p53 enhanced the expression of a test gene driven by the multi-drug resistance enhancer-promoter.

    Conclusions:

    • Mutant p53 proteins can exhibit a gain of function, conferring novel oncogenic phenotypes.
    • These findings demonstrate that p53 mutations can lead to both loss of tumor suppression and acquisition of new oncogenic functions.
    • The gain of function by mutant p53 may contribute to tumor development and progression.